Figure 7.
In vivo tumor inhibition of Bi2Se3/DOX@MPs. Relative a) tumor volumes and b) body weights of H22 tumor‐bearing BALB/c mice after different treating. c) Representative photos and average tumor weight of excised tumors 15 days after treatments. d) H&E staining (200 ×) of the tumor tissues after the indicated treatments.